STAA vs USB · rev $313.9M vs P/E 12, rev $28.66B
STAAR Surgical Company (STAA) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
STAA currently screens at market cap $1.45B. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the STAA and USB stock pages for the full models.
Not investment advice.